• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

Galaxy Medical, Japan Lifeline ink distribution agreement for ablation catheters

May 12, 2021 By Danielle Kirsh

galaxy medical-japan lifelineGalaxy Medical and Japan Lifeline today said they signed an exclusive distribution agreement for the Alpha1 ablation catheter.

Under the agreement Galaxy will pursue U.S. regulatory approval for Japan Lifeline’s Alpha1 in support of the commercialization of Galaxy’s Centauri pulsed electric field system, which can be used with the ablation catheter.

Alpha1 is designed to handle increased electrical demands associated with pulsed electric field therapy without having to sacrifice the handling, flexibility or expected feel.

The ablation catheter has an 8 Fr outer diameter, 4 mm platinum ablation tip and a full 180 degrees of bilateral deflection. It works with two features unique to the Centauri PEF system: the Wave1 waveform that reduces muscle stimulation and eliminates microbubbles and the Centauri Connect box that allows physicians to perform PEF ablation procedures with focal catheters and mapping systems in radiofrequency procedures.

“We have long sought to bring our outstanding ablation technologies to the US market. In this partnership with Galaxy and their expertise in PEF technology, we aim to be at the forefront of innovation in ablation, bringing new therapies to the millions of people worldwide who suffer from cardiac arrhythmias,” Japan Lifeline CEO Kei Suzuki said in a news release.

“We are thrilled to partner with Japan Lifeline on the first focal PEF system. Over the last several months, Galaxy and JLL engineers have collaborated to design Alpha1, allowing PEF energy to target a wide array of arrhythmias,” Galaxy Medical CEO Jonathan Waldstreicher said. “We chose to start with a focal approach because 87% of catheter ablations worldwide are performed in this manner, aligning with our mission of democratizing the use of PEF energy. As we embark on clinical trials with the system, we hope to demonstrate enhanced safety and efficacy as compared to today’s standard of care.”

Filed Under: Catheters Tagged With: galaxy medical, Japan Lifeline

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS